Efficacy of gene xpert over other diagnostic modalities of tuberculosis among children


  • Deepmala Pandey Department of Neonatology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
  • Ankur Yadav Department of Neonatology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India




Children, Diagnostic modalities, Efficacy, Genexpert, Tuberculosis


Background: Diagnosis of tuberculosis is a challenge especially among children. GeneXpert has been recommended as a diagnostic test in children. Objectives of this study was to efficacy of GeneXpert over other diagnostic modalities of Tuberculosis like Sputum smear microscopy, Mantoux testing, X-ray chest among children.

Methods: A cross sectional hospital-based study was conducted over a period of 24 months among 150 children. All the patients who were having suspicion of Tuberculosis on the basis of History & Examination (fulfilling inclusion criteria) had been enrolled in the study. After doing all preliminary investigations clinical diagnosis has been made and Gene X’pert was carried out for all the samples collected. Pearson chi square test and Fishers exact test was applied wherever appropriate.

Results: There was statistically no significant (p >0.05) difference of GeneXpert positivity within different age groups of Suspected TB patients. GeneXpert was positive in 80% with symptom of Cough lasting more than 2 weeks, in 78.8% with fever more than 2 weeks, in 88.9% with FTT, in 76.5% with H/O Koch’s contact, in 77.8% with H/O convulsion, in 69% with significant lymphadenopathy. GeneXpert was positive in all suspected TB patients having ZN staining positive for AFB. In clinically TB diagnosed patients, 86.5% were positive for GeneXpert.

Conclusions: GeneXpert is a novel diagnostic modality of choice in all suspected Pulmonary & Extra-pulmonary TB cases among children. It can be used as a primary tool in Pulmonary TB with smear negative samples in pediatric age group.


Zumla A, George A, Sharma V, Herbert RH, Oxley A, Oliver M. The WHO 2014 global tuberculosis report-further to go. Lancet Glob Heal. 2015;3(1):e10-2.

World Health Organization. Tuberculosis. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed on: 01-05-2015.

Central TB Division. Directorate General of Health Services. Ministry of Health and Family Welfare. Annual status report, TB India 2015. Available at: https://tbcindia.gov.in/showfile.php?lid=3166 Accessed 01 May 2015.

Donald PR. Childhood tuberculosis: out of control? Curr Opin Pulm Med. 2002;8(3):178-82.

World Health Organization. Global Tuberculosis 2014 report updates 1-2. Available at: https://www.who.int/tb/publications/global_report/gtbr14_main_text.pdf Accessed 01 May 2015.

Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis. 2012;55(8):1088-95.

Ndugga KLE, Clee MR, Githui WA, Nganga LW, Kibuga DK, Odhiambo JA, et al. A comprehensive comparison of Ziehl-Neelsen and uorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int J Tuberc Lung Dis. 2003;7(12):1163-71.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Jones M, Allen J, et al. Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med. 2010;363:1005-15.

Banada PP, Sivasubramani SK, Blakemore R, Boehme C, Perkins MD, Fennelly K, et al. Containment of bio-aerosol infection risk by the X’pert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol. 2010;48(10):3551-7.

Reither K, Manyama C, Clowes P, Rachow A, Mapamba D, Steiner A, et al. X’pert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation. J Infect. 2015;70(4):392-9.

Chadha VK, Kumar P, Satyanarayanan AV, Chauhan LS, Gupta J, Singh S, et al. Annual risk of tuberculosis infection in Andhra Pradesh, India. Indian J Tuberc. 2007;54(4):177-83.

Rao VG, Gopi PG, Yadav R, Subramani R, Bhat J, Anvikar AR, et al. Annual risk of tuberculosis infection among tribal population of Central India. Trop Med Int Heal. 2008;13(11):1372-7.

Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D, et al. Instability of Delayed-Type Hypersensitivity Skin-Test Anergy in Human- Immunodeficiency-Virus Infection. Arch Int Med. 1995;155(19):2111-7.

Bunsow E, Ruiz-Serrano MJ, Roa PL, Kestler M, Viedma DG, Bouza E, et al. Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampicin in clinical specimens. J Infect. 2014;68(4):338-43.

Zmak L, Jankovic M, Jankovic VK. Evaluation of X’pert MTB/RIF assay for rapid molecular diagnosis of tuberculosis in a two-year period in Croatia. Int J Mycobacteriol. 2013;2(3):179-182.

Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, Cunningham J, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(10):664-74.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;1:CD009593.

Sachdeva KS, Raizada N, Sreenivas A, Hoog AH, Hof S, Dewan PK, et al. Use of X’pert MTB/RIF in decentralized public health settings and its effect on pulmonary TB and DR- TB case finding in India. PloS One. 2015;10(5):e0126065.

World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: X’pert MTB/RIF Assay for the Diagnosis of Pulmonary and Extra pulmonary TB in Adults and Children: Policy Update. Geneva 2013. Available at: https://apps.who.int/iris/bitstream/handle/10665/112472/9789241506335_eng.pdf?sequence=1. Accessed 01 May 2015.

Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007;11:1-196.

Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-12.

Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003;3(10):633-43.

Lawn SD, Nicol MP. Xpert MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6(9):1067-82.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N, et al. pert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, e Cochrane Database Sys Rev. 2014;1:CD009593.






Original Research Articles